Clinical trial
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
NCT00239798 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00239798 |
|---|---|
| Title | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients |
| Official title | A 24-month Extension of a One-year, Multicenter, Double Blinded Double Dummy, Randomized Study to Evaluate the Safety and Efficacy of Two Doses of FTY720 Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Steroids Versus Mycophenolate Mofetil Combined With Full-dose… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | FTY720 |
| Enrollment | 255 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | Feb 23, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: